Bone Biomarkers in Mucopolysaccharidoses
Open Access
- 23 November 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (23) , 12651
Abstract
The accumulation of glycosaminoglycans (GAGs) in bone and cartilage leads to progressive damage in cartilage that, in turn, reduces bone growth by the destruction of the growth plate, incomplete ossification, and growth imbalance. The mechanisms of pathophysiology related to bone metabolism in mucopolysaccharidoses (MPS) include impaired chondrocyte function and the failure of endochondral ossification, which leads to the release of inflammatory cytokines via the activation of Toll-like receptors by GAGs. Although improvements in the daily living of patients with MPS have been achieved with enzyme replacement, treatment for the bone disorder is limited. There is an increasing need to identify biomarkers related to bone and cartilage to evaluate the progressive status and to monitor the treatment of MPS. Recently, new analysis methods, such as proteomic analysis, have identified new biomarkers in MPS. This review summarizes advances in clinical bone metabolism and bone biomarkers.Keywords
This publication has 76 references indexed in Scilit:
- Sox9 Directs Hypertrophic Maturation and Blocks Osteoblast Differentiation of Growth Plate ChondrocytesDevelopmental Cell, 2012
- Biomarker analysis of Morquio syndrome: identification of disease state and drug responsive markersOrphanet Journal of Rare Diseases, 2011
- Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease)Orphanet Journal of Rare Diseases, 2011
- Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disordersThe EMBO Journal, 2010
- Mucopolysaccharidosis VIOrphanet Journal of Rare Diseases, 2010
- Altered lumbar spine structure, biochemistry, and biomechanical properties in a canine model of mucopolysaccharidosis type VIIJournal of Orthopaedic Research, 2009
- Mechanism of shortened bones in mucopolysaccharidosis VIIMolecular Genetics and Metabolism, 2009
- Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VIPathoGenetics, 2009
- Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damageAnnals of the Rheumatic Diseases, 2007
- Wnt gene expression in the post-natal growth plate: Regulation with chondrocyte differentiationBone, 2007